Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Kedudukan dalam Saham #32247
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Harga Saham
$0.8013
Disegerakkan terakhir: 2026-08-05
Modal Pasaran
$10.62M
Perubahan (1 hari)
0.97%
Perubahan (1 tahun)
-37.88%
Negara
US
Perdagangan Hoth Therapeutics, Inc. (HOTH)

Kategori

Sejarah hasil dividen untuk Hoth Therapeutics, Inc. (HOTH)
Hasil dividen (TTM) bagi Hoth Therapeutics, Inc. (simbol saham: HOTH) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Hoth Therapeutics, Inc. (HOTH) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing